🇪🇺 Reyataz in European Union

EMA authorised Reyataz on 2 March 2004

Marketing authorisation

EMA — authorised 2 March 2004

  • Status: approved

Reyataz in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in European Union

Frequently asked questions

Is Reyataz approved in European Union?

Yes. EMA authorised it on 2 March 2004.

Who is the marketing authorisation holder for Reyataz in European Union?

Bristol-Myers Squibb is the originator. The local marketing authorisation holder may differ — check the official source linked above.